{"id":15219,"date":"2020-02-13T07:07:21","date_gmt":"2020-02-13T12:07:21","guid":{"rendered":"https:\/\/medicarereport.org\/?p=15219"},"modified":"2020-02-13T07:09:22","modified_gmt":"2020-02-13T12:09:22","slug":"15219","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=15219","title":{"rendered":"Key proposals in the Proposed Rule for Medicare Advantage and Part D for Year 2021 and 2022"},"content":{"rendered":"<p>The Centers for Medicare and Medicaid Services (CMS) issues a proposed rule advancing multiple updates and changes to Medicare Advantage (MA) and Medicare prescription drug benefit (Part D) programs.\u00a0 CMS is breaking with tradition and will not publish a \u201cCall Letter\u201d -an annual regulatory policy document that establishes payment and coverage policies for MA and Part D plans for the upcoming plan year- for MA and Part D programs in 2020. To read a brief overview of the key proposals in the Proposed Rule, click <a href=\"https:\/\/www.jdsupra.com\/legalnews\/cms-issues-medicare-advantage-and-part-73142\/\">here\u2026 <\/a>to read attached article.<\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/CMS-logo-2-e1524659904197.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10228\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/CMS-logo-2-300x150.jpg\" alt=\"\" width=\"300\" height=\"150\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>The Centers for Medicare and Medicaid Services (CMS) issues a proposed rule advancing multiple updates and changes to Medicare Advantage<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,21,20,9,15],"tags":[],"class_list":["post-15219","post","type-post","status-publish","format-standard","hentry","category-cms","category-health-care-finance","category-health-care-redesign","category-medicare-advantage","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15219"}],"version-history":[{"count":3,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15219\/revisions"}],"predecessor-version":[{"id":15222,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15219\/revisions\/15222"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}